Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26124
Title: Volumetric arc therapy: A viable option for right-sided breast with comprehensive regional nodal irradiation in conjunction with deep inspiration breath hold.
Austin Authors: Holt, Emily;Mantel, Amanda;Cokelek, Margaret;Tacey, Mark A ;Jassal, Sunny;Law, Michael;Zantuck, Natalie;Yong, Charles;Cheng, Michael;Viotto, Angela ;Foroudi, Farshad ;Chao, Michael
Affiliation: Olivia Newton-John Cancer Wellness and Research Centre
GenesisCare Victoria, Ringwood Private Hospital, VIC, Australia
Melbourne School of Population and Global Health, University of Melbourne, Carlton, VIC, Australia
Maroondah Hospital, Ringwood East, VIC, Australia
Issue Date: Jun-2021
Date: 2021-03-23
Publication information: Journal of Medical Imaging and Radiation Sciences 2021; 52(2): 223-237
Abstract: Deep inspiration breath hold (DIBH) is an innovative technique routinely used for left-sided breast radiotherapy to significantly reduce harmful dose to the heart and ipsilateral lung. Currently, there is scant literature exploring DIBH for right-sided whole breast and regional nodal irradiation (WB & RNI). The purpose of this study is to examine if DIBH produces a clinically significant reduction in organ at risk (OAR) dose for right-sided WB + RNI, whilst comparatively analysing the use of volumetric arc therapy (VMAT) versus tangential inverse modulated radiotherapy (t-IMRT). Ten patients, previously treated for left sided breast cancer (with a FB and DIBH CT scan), were selected from our database to be retrospectively replanned to the right breast and nodal regions. Planning target volumes (PTV) were marked to include the whole right breast and regional nodes, encompassing the supraclavicular fossa (SCF) and internal mammary nodes (IMN). PTVs and OARs were contoured on the Pinnacle workstation according to the Radiation Therapy Oncology Group (RTOG) guidelines. VMAT and t-IMRT plans were generated to a prescribed dose of 50 Gy in 25 fractions on both the DIBH and FB data sets for dosimetric analysis. Coverage of the right breast (mean, D95%) and SCF (D95%) were significantly improved with VMAT in comparison to t-IMRT, with no statistically significant variation on the IMN PTV (D95%). The use of DIBH did not impact PTV coverage compared with FB. VMAT reduced dose to the ipsilateral lung (mean, V20Gy), combined lungs (mean, V20Gy) and liver (D2cc); conversely dose to the heart (mean), left lung (mean, V5Gy) and contralateral breast (mean) were increased. For both techniques DIBH significantly improved dose to OARs including the ipsilateral lung (mean, V20Gy, V5Gy), total lung (mean, V20Gy), heart (mean, V25Gy) and liver (D2cc) when compared to FB. DIBH could be considered for patients treated with right-sided WB and RNI due to a significant decrease in heart, ipsilateral lung, total lung and liver doses. VMAT significantly improves PTV coverage over t-IMRT whilst reducing dose to the ipsilateral lung and liver, albeit to the detriment of the left lung, contralateral breast and heart. The increase in heart dose can be mitigated by the use of DIBH. We recommend if VMAT is utilised for superior target volume coverage, DIBH should also be implemented to reduce OAR toxicity.
URI: https://ahro.austin.org.au/austinjspui/handle/1/26124
DOI: 10.1016/j.jmir.2021.02.007
Journal: Journal of Medical Imaging and Radiation Sciences
PubMed URL: 33771509
Type: Journal Article
Subjects: Heart
IMRT
Lung
PTV
Radiotherapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

50
checked on Jul 16, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.